A Phase 3 Study Comparing 2 Doses Of CP-690,550 vs. Placebo For Treatment Of Psoriatic Arthritis

Written by ClinicalTrials.gov

Category: Spine Diseases

Published: 17 June 2011

Condition: Psoriatic Arthritis
Interventions: Drug: Tofacitinib (CP-690,550); Drug: Tofacitinib (CP-690,550); Drug: Placebo; Drug: Placebo
Sponsor: Pfizer
Not yet recruiting - verified August 2011

Details: Last Updated: 17 June 2011

Find, Use, Share, Expand Orthopaedic Information

Improving orthopaedic care, education and research using Internet technologies